U.S. markets closed

Akamai Technologies, Inc. (AKAM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
104.23+0.36 (+0.35%)
At close: 4:00PM EDT

104.20 -0.03 (-0.03%)
After hours: 5:54PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close103.87
Bid103.11 x 1100
Ask104.50 x 800
Day's Range103.17 - 104.71
52 Week Range92.64 - 124.91
Avg. Volume2,188,775
Market Cap17.012B
Beta (5Y Monthly)0.41
PE Ratio (TTM)30.93
EPS (TTM)3.37
Earnings DateApr 26, 2021 - Apr 30, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est125.62
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
8% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Akamai Technologies Elects Sharon Y. Bowen to Board Of Directors
    PR Newswire

    Akamai Technologies Elects Sharon Y. Bowen to Board Of Directors

    Akamai Technologies, Inc. (NASDAQ: AKAM), the world's most trusted solution for protecting and delivering digital experiences, today announces the appointment of Sharon Y. Bowen to fill a newly-created vacancy on the Akamai Board of Directors effective April 2, 2021.

  • Is AKAM Stock A Buy or Sell?
    Insider Monkey

    Is AKAM Stock A Buy or Sell?

    Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […]

  • Akamai (AKAM) Rolls Out COVID-19 Vaccine Management Offering

    Akamai (AKAM) Rolls Out COVID-19 Vaccine Management Offering

    Akamai (AKAM) introduces Vaccine Edge, complementing salesforce's new Vaccine Cloud to enable a large number of users to register for virtual appointments in a hassle-free manner.